メタ情報
| meta description平均長 | 152.06 |
|---|
| OGPありページ数 | 51 |
|---|
| Twitterカードありページ数 | 51 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 86 |
|---|
| ページあたり内部リンク平均 | 43.43 |
|---|
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| clinical | 1 |
| medical | 0.969706 |
| patients | 0.773707 |
| trials | 0.698615 |
| PAI | 0.67848 |
| research | 0.668647 |
| development | 0.651167 |
| RS5614 | 0.629933 |
| have | 0.622562 |
| drugs | 0.578057 |
| trial | 0.565041 |
| disease | 0.556852 |
| not | 0.546281 |
| initiated | 0.533591 |
| investigator | 0.506911 |
| University | 0.502206 |
| was | 0.491228 |
| nivolumab | 0.468387 |
| lung | 0.448731 |
| our | 0.447436 |
| drug | 0.440431 |
| treatment | 0.438976 |
| data | 0.435125 |
| Phase | 0.434645 |
| cancer | 0.423872 |
| E3 | 0.423059 |
| can | 0.417249 |
| immune | 0.41026 |
| diseases | 0.404044 |
| rate | 0.39284 |
| aging | 0.385396 |
| combination | 0.385396 |
| Tohoku | 0.380117 |
| been | 0.362573 |
| such | 0.360532 |
| Japan | 0.353895 |
| many | 0.351181 |
| has | 0.343381 |
| checkpoint | 0.332403 |
| than | 0.331671 |
| また | 0.326526 |
| melanoma | 0.323235 |
| institutions | 0.319371 |
| there | 0.315117 |
| also | 0.311281 |
| pharmaceutical | 0.304251 |
| 当社は | 0.302993 |
| Furthermore | 0.302185 |
| vascular | 0.302185 |
| e3 | 0.298371 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| initiated | investigator | 4.68617 | 220 |
| Tohoku | University | 4.515677 | 275 |
| clinical | trials | 3.999125 | 337 |
| checkpoint | immune | 3.780192 | 87 |
| artificial | intelligence | 3.725518 | 56 |
| Healthspan | XPRIZE | 3.7148 | 88 |
| Graduate | School | 3.67078 | 64 |
| Medicine | School | 3.667928 | 72 |
| intellectual | property | 3.611374 | 52 |
| coronavirus | novel | 3.558866 | 60 |
| announce | pleased | 3.545793 | 40 |
| cutting | edge | 3.519866 | 44 |
| https | www | 3.513175 | 76 |
| Inc | Renascience | 3.467021 | 74 |
| Miyata | Toshio | 3.361033 | 36 |
| expectancy | life | 3.356552 | 53 |
| clinical | initiated | 3.3126 | 218 |
| leukemia | myeloid | 3.285661 | 36 |
| like | would | 3.267156 | 41 |
| malignant | melanoma | 3.253552 | 62 |
| States | United | 3.246518 | 32 |
| Abdullah | King | 3.246518 | 32 |
| 仙台市 | 東北大学スマートフロンティア協議会 | 3.230545 | 29 |
| ウェルネス分科会 | 東北大学スマートフロンティア協議会 | 3.230545 | 29 |
| Good | Practice | 3.21324 | 40 |
| combination | nivolumab | 3.206403 | 75 |
| been | has | 3.199177 | 138 |
| effects | side | 3.182378 | 47 |
| adverse | events | 3.180541 | 32 |
| animal | models | 3.171816 | 40 |
| ipilimumab | nivolumab | 3.1513 | 55 |
| Arabia | Saudi | 3.137627 | 48 |
| Council | Frontier | 3.131587 | 28 |
| Council | Wellness | 3.131587 | 28 |
| Subcommittee | Wellness | 3.131587 | 28 |
| City | Sendai | 3.130969 | 36 |
| checkpoint | molecules | 3.080025 | 45 |
| angiosarcoma | cutaneous | 3.068135 | 32 |
| Frontier | Smart | 3.061061 | 28 |
| injury | lung | 3.026436 | 65 |
| Hub | Medicinal | 2.998875 | 24 |
| label | off | 2.922886 | 24 |
| ウェルネス分科会 | 仙台市 | 2.875475 | 24 |
| endpoint | primary | 2.853163 | 25 |
| Graduate | Medicine | 2.852263 | 45 |
| Japanese | Society | 2.842091 | 20 |
| mentally | physically | 2.842091 | 20 |
| engineered | genetically | 2.842091 | 20 |
| サウジ | ビジョン2030 | 2.826481 | 19 |
| chronic | myeloid | 2.82078 | 36 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録